Evidence map›Paper›PMID 31088987›Full record

ArticleRespiratory care2019

A Respiratory Therapist-Driven Asthma Pathway Reduced Hospital Length of Stay in the Pediatric Intensive Care Unit.

Andrew G Miller, Kaitlyn E Haynes, Rachel M Gates, Kanecia O Zimmerman, Travis S Heath, Kathleen W Bartlett, Heather S McLean, Kyle J Rehder

Abstract read
In one paragraph

Article in Respiratory care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Validation of a structured questionnaire to assess the perception and satisfaction of respiratory therapy students toward career prospects and learning resources.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Andrew G MillerRespiratory Care Services at Duke University Medical Center, Durham, North Carolina. andrew.g.miller@duke.edu.
Kaitlyn E HaynesRespiratory Care Services at Duke University Medical Center, Durham, North Carolina.
Rachel M GatesRespiratory Care Services at Duke University Medical Center, Durham, North Carolina.
Kanecia O ZimmermanDivision of Pediatric Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.
Travis S HeathDepartment of Pharmacy, Duke University Medical Center, Durham, North Carolina.
Kathleen W BartlettDivision of Pediatric Hospital Medicine, Duke University Medical Center, Duke University Medical Center, Durham, North Carolina.
Heather S McLeanDivision of Pediatric Hospital Medicine, Duke University Medical Center, Duke University Medical Center, Durham, North Carolina.
Kyle J RehderDivision of Pediatric Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.

Funding

Investigating polypharmacy-related adverse events in critically ill children using electronic health records and simulated drug levelsK23HD091398 · NICHD · DUKE UNIVERSITY · PI ZIMMERMAN, KANECIA OBIE · 2017 to 2020
$629k
NICHD NIH HHS K23 HD091398
6 · The paper itself

Abstract

backgroundAsthma is a common reason for admissions to the pediatric intensive care unit (PICU). Since June 2014, our institution has used a pediatric asthma clinical pathway for all patients, including those in PICU. The pathway promotes respiratory therapist-driven bronchodilator weaning based on the Modified Pulmonary Index Score (MPIS). This pathway was associated with decreased hospital length of stay (LOS) for all pediatric asthma patients; however, the effect on PICU patients was unclear. We hypothesized that the implementation of a pediatric asthma pathway would reduce hospital LOS for asthmatic patients admitted to the PICU.

methodsWe retrospectively reviewed the medical records of all pediatric asthma subjects 2-17 y old admitted to our PICU before and after pathway initiation. Primary outcome was hospital LOS. Secondary outcomes were PICU LOS and time on continuous albuterol. Data were analyzed using the chi-square test for categorical data, the

resultsA total of 203 eligible subjects (49 in the pre-pathway group, 154 in the post group) were enrolled. There were no differences between groups for age, weight, gender, home medications, cause of exacerbation, medical history, or route of admission. There were significant decreases in median (interquartile range) hospital LOS (4.4 [2.9-6.6] d vs 2.7 [1.6-4.0] d,

conclusionThe implementation of an asthma pathway was associated with decreased hospital LOS, PICU LOS, and time on continuous albuterol. There was also an increase in the use of high-flow nasal cannula and noninvasive ventilation after the implementation of this clinical pathway.

Indexed as

Critical PathwaysAdolescentAlbuterolAsthmaBronchodilator AgentsChildChild, PreschoolClinical ProtocolsFemaleHumansIntensive Care Units, PediatricLength of StayMalePatient ReadmissionRespiratory TherapyStatus AsthmaticusAlbuterolBronchodilator Agentsasthmaasthma pathwayhigh-flow nasal cannulapropensity score matchingprotocolquality improvementrespiratory therapystatus asthmaticus

Identifiers

PMID31088987
PMCPMC6945301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.